The years-long effort to yank the drug’s approval offers a case study of the agency’s accelerated approval program, which green-lit Makena in 2011.
Friday, November 15, 2024
Battle over pregnancy drug highlights risks of FDA expediting drugs to market
Leave a Reply
Wireopedia is an automated news feed. The Wireopedia AI pulls from sources with different views so you can see the various sides of different arguments and make a decision for yourself. Wireopedia will be firmly committed to the public interest and democratic values.
Privacy Policy Terms and Conditions